AzTrials
AzTrials

Advance Care PlanningNCT02463162

Trial of Advance Care Planning (ACP) & Goals of Care Designations (GCD) Discussions

A study testing Conversations Matter videos in people with Advance Care Planning and Goals of Care, run by University of Alberta at 15 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Canadian population is aging and more people are living with advanced chronic diseases. At the end of life (EOL), the use of invasive medical treatments in hospitals is increasing and associated with worse outcomes. Advance Care Planning (ACP) may help improve care at EOL to be the way patients want it. Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Advance Care Planning, Goals of Care
What is being tested?
Conversations Matter videos
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
15 sitesCanada
Study dates
Jun 2015to Nov 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosis of either:
  • heart failure classified as Class III or IV based on New York Heart Association Functional Classification or classified as Stage D based on American Heart Association/American College of Cardiology Heart Failure Classification;
  • renal failure and on dialysis; or
  • metastatic lung, gastrointestinal (including pancreatic) or gynecological cancer and on chemo, radiation therapy or palliative
  • 19 or over
  • able to communicate in English
  • reside within 100 km of Edmonton or Calgary
  • owns a phone

Who cannot join

  • cognitive impairment which would impact ability to give informed consent
  • in crisis
  • first visit or in the case of renal patients, in the first month of dialysis
  • participated in ACP pilot study
  • visual and/or hearing impairment that would impact their ability to see and/or hear the Videos, and/or complete the assessments including the telephone follow-up interviews.

Trial locations and contacts

15 sites in 1 country.

15 sites in 1 country

Canada15 sites
  • Peter Lougheed Centre: Heart Function Clinic

    Calgary, Alberta, T1Y 6J4

  • Sunridge Dialysis Unit: Hemodialysis

    Calgary, Alberta, T1Y 7M8

  • Southern Alberta Renal Program - Northlands Village Mall, Hemodialysis

    Calgary, Alberta, T2L 2J8

  • Foothills Medical Centre: Heart Function and Heart Transplant Clinic

    Calgary, Alberta, T2N 2T9

  • Tom Baker Cancer Centre

    Calgary, Alberta, T2N 4N2

  • Sheldon M. Chumir Health Centre: Hemodialysis

    Calgary, Alberta, T2R 0X7

  • Rockyview General Hospital: Heart Function Clinic

    Calgary, Alberta, T2V 1P9

  • South Calgary Health Centre: Hemodialysis

    Calgary, Alberta, T2X 3W5

  • South Health Campus: Heart Function Clinic

    Calgary, Alberta, T3M 1M4

  • Royal Alexandra Hospital: Renal Insufficiency Clinic and Hemodialysis Unit

    Edmonton, Alberta, T5H3V9

  • Edmonton General Continuing Care Centre: Hemodialysis

    Edmonton, Alberta, T5K 0L4

  • Cross Cancer Institute

    Edmonton, Alberta, T6G 1Z2

  • Mazankowski Alberta Heart Institute

    Edmonton, Alberta, T6G 2B7

  • University of Alberta Hospital: Renal Insufficiency Clinic and Hemodialysis Units

    Edmonton, Alberta, T6G2B7

  • Grey Nuns Community Hospital: Renal Insufficiency Clinic and Hemodialysis Unit

    Edmonton, Alberta, T6L 5X8

Other trials in Canada

About this study

Official title: Effectiveness and Economic Impact of Advance Care Planning and Goals of Care Designations Discussions: A Randomized Controlled Trial

The Canadian population is aging and more people are living with advanced chronic diseases. At the end of life (EOL), the use of invasive medical treatments in hospitals is increasing and associated with worse outcomes. Advance Care Planning (ACP) may help improve care at EOL to be the way patients want it. ACP is a process where people think about the various options related to future health care decisions and they may communicate with a verbal or written plan of what care they would want in the EOL. Also, they may nominate a substitute decision maker if they become unable to speak for themselves. A national poll found that few Canadians have thought about or made an ACP.

Alberta Health Services has developed two videos (Videos) to help with decision making about ACP and goals of care designations(GCD). GCD are medical orders of care that (a) serve as a communication tool for HCP to assist in rapid decision making; and (b) guide HCP and patients regarding the general intent and locations of care, and interventions that are to be provided. This study will compare ACP behaviours and GCD preferences for participants who have seen the Videos with those who have not and measure the change in those behaviours and preferences at 1, 2 and 3 months. It will also look at the impact of the Videos on health care costs and service use. Participants from five patient groups (metastatic lung cancer, colorectal cancer, gynecological cancer, renal failure, and heart failure) were selected as representative of where ACP should ideally be occurring, and where data on ACP implementation is presently most lacking, and as venues in which this research is most feasible. Collecting information about patients' ACP and GCD preferences may help improve AHS decision making tools and more generally help healthcare leaders plan ways to better engage patients in the ACP process.

Read the detailed description

Background: Respecting patients' preferences for treatment is a key component of high quality end of life care. Alberta Health Services (AHS) has developed tools for public, patient and healthcare provider (HCP) engagement and education (such as guidebooks, videos, and HCP training modules) to support widespread engagement in advance care planning (ACP) and determining Goals of Care Designation (GCD). However, none of these knowledge translation (KT) tools have been validated and they have not been tailored to reflect barriers in the local context.

ACP is defined as a communication process where people plan for a time when they cannot make medical decisions for themselves. It includes thinking about and communicating their preferences for future healthcare, which can include conversations with family and healthcare providers, choosing and documenting an alternate decision maker, and/or documenting preferences for healthcare for use in the event that person loses capacity for medical decision-making. These discussions can occur both informally and formally. Goals of Care Designations (GCD) are medical orders of care that (a) serve as a communication tool for HCP to assist in rapid decision making; and (b) guide HCP and patients regarding the general intent and locations of care, and interventions that are to be provided. Decisions about goals of care usually arise over time through conversations between patients, family members and the health care team.

This randomized controlled trial (RCT) will focus on the two Conversations Matter Video decision-aids developed by AHS for people and their families. The first video is an 8-minute video that describes the 5-steps of the ACP process. The second video is a 8-minute video that illustrates the resuscitative, medical and comfort levels of care outlined in the Alberta GCD policy.

Scope: This protocol relates to two of the research activities designed to evaluate the impact of ACP/GCD. The first is an RCT to evaluate the effectiveness of two videos about ACP and GCD. Participants will be recruited from settings where ACP should ideally be occurring, and where data on ACP implementation is presently most lacking. The overall aim of the RCT is to evaluate and refine these existing knowledge translation (KT) tools to optimize the quality and frequency of patient education about and engagement in ACP and determining goals of care.

The second activity measures the economic impact of the Videos in these patient populations. A significant proportion of health care resources are consumed at end of life. ACP, which emphasizes discussions, combined with GCD, may have a greater impact than advance directives alone. To be clear, the primary goal of ACP is not about cost containment, but rather, to shift a culture of care toward a patient- and family-centered approach to medical decision-making. Prospective data collection and analysis will give insight into personal and intangible costs. It will allow for relatively precise measurement of health care savings, and thereby inform health care systems on anticipated savings and prescribe shift of funding necessary for appropriate resourcing in parts of the health care system that may see increased activity because of ACP, while also improving quality of patient-centred outcomes.

Methods: The RCT will be an in-person intervention and survey at baseline, follow-up telephone survey at one month and two months, and in-person survey at three months. At baseline, researchers will assess function and ask about demographic information, quality of life, advance care planning (ACP), and goals of care (GC) preferences and goals of care designation orders (GCD). Participants will then be randomized between two arms:

  1. control or "usual care"; and
  2. intervention whereby participant views two videos about ACP and GCD, respectively (Videos).

Surveys will be administered by research staff. The baseline intervention and survey will take approximately 30 to 65 minutes, depending on which arm the participant is randomized to, and be collected from up to 240 participants. At one, two and three months, follow up surveys will be administered to collect data about health care services utilized, health care costs incurred, and discussions about ACP and GC with their health care providers, lawyers, financial advisors and/or clergy in the preceding month. The one and two month surveys will be approximately 10-20 minutes in length. Three-month follow-up surveys will collect data about ACP, GC preferences and GCD and will be approximately 20-40 minutes in length. Researchers will also collect data from participants' electronic medical health records about their diagnosis and co-morbidities, health services utilization and costs at 12 months prior to baseline, baseline and approximately 12 months after baseline.

Objectives:

  1. Determine the effectiveness of the Videos by comparing the change from baseline to 1, 2 and 3 months of the number of participants who have had a conversation with a health care provider about ACP or GCD between two groups, namely: those who receive no intervention (usual care) and those who watch the Videos.
  2. Determine the cost and economic consequences of the Videos by comparing the change from 12 months prior to baseline to and including baseline, to 1 month, 2, months, 3 months and 12 months following baseline in health care utilization and costs between the two groups described in Objective 1.
Being tested
Conversations Matter videos

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conversations Matter videosOther

    2 videos about Advance Care Planning and Goals of Care Designations respectively. These 2 videos were developed by Alberta Health Services and are each 8 minutes long.

Study groups in NCT02463162
Study groupRoleWhat they receive
ControlNo interventionThis group will receive "usual care" which is to receive no intervention.
InterventionExperimentalThis group will receive the intervention which is two Conversations Matter videos about Advance Care Planning and Goals of Care Designations respectively
Receives: Other: Conversations Matter videos

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Video effectiveness measured by change from baseline in number of participants who have had a conversation with a health care provider about ACP or GCD to 1 month, 2 months and 3 months

    Determine the effectiveness of the Videos by comparing the number of participants who have had a conversation with a health care provider about ACP or GCD between two groups (those who receive the intervention (usual care) and those who watch the videos

    Measured: 1 month, 2 months and 3 months

  2. Economic impact of Videos measured by comparing change from 12 months prior to baseline in health care costs to baseline, 1 month, 2 months, 3 months and 12 months after baseline between two groups

    Determine the cost and economic consequences of the Videos by comparing change in health care costs between two groups (those who receive no intervention (usual care) and those who watch the Videos)

    Measured: 12 months prior to baseline, baseline, 1 month, 2 months, 3 months and 12 months after baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2015 (estimated)
  2. Study startJun 2015
  3. Primary completionNov 2016
  4. Study completionNov 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
240 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02463162
Sponsor's protocol ID
Pro00054953
Status last verified
May 2017
First submitted
28 May 2015
Last updated
9 May 2017
Results posted
No
Data monitoring committee
No

Publications

  • Douglas ML, Simon J, Davison SN, Biondo P, Ghosh S, Kassam A, Fassbender K. Efficacy of Advance Care Planning Videos for Patients: A Randomized Controlled Trial in Cancer, Heart, and Kidney Failure Outpatient Settings. Med Decis Making. 2021 Apr;41(3):292-304. doi: 10.1177/0272989X20985836. Epub 2021 Jan 15.

    PubMed 33451263

Questions about this trial

What is this clinical trial studying?

A study testing Conversations Matter videos in people with Advance Care Planning and Goals of Care, run by University of Alberta at 15 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 15 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Video effectiveness measured by change from baseline in number of participants who have had a conversation with a health care provider about ACP or GCD to 1 month, 2 months and 3 months (time frame: 1 month, 2 months and 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02463162, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in